Partnership establishes a collaboration framework to combine two FDA-cleared platforms to address unmet needs in robotic navigation
Interventional Systems (INS), a pioneer in miniature medical robotics, and ProVoyance, a medical technology company providing an AI-powered surgical planning platform, today announced a strategic platform partnership to explore and develop integrated robotic navigation capabilities. The partnership brings together two FDA-cleared platforms — INS’s Micromate™ miniature robot and ProVoyance’s AI-enabled preoperative planning software — into a collaboration framework to deliver seamless, end-to-end solutions for OEM partners and the surgeons and patients they serve.
The two companies will combine their expertise to co-develop solutions to improve surgical accuracy, streamline workflows, and expand access to robotic navigation across surgical care settings. For OEM partners, building on two already-cleared platforms represents a meaningful competitive advantage, reducing significant time, cost, and regulatory risk from the product development cycle.
“We are enthusiastic about the possibility of partnering with experts such as ProVoyance, as it further reinforces both companies’ commitment to exploring synergies, with both humility and ambition. The integration of ProVoyance’s intelligent surgical planning with our differentiated approach to robotics is a force multiplier for OEM partners aiming to integrate cost-effective yet cutting-edge enabling technologies into their portfolios”
— Pedro Costa, Chief Strategy Officer, Interventional Systems
“We are thrilled to be partnering with Interventional Systems — a team that shares our conviction that the future of orthopedic surgery is intelligent, mobile, and accessible. Micromate’s cleared, mobile robotic platform will transform ProVoyance into a complete, validated end-to-end workflow that OEM partners can integrate and bring to market with confidence. We built ProVoyance to make intelligent surgical planning accessible at scale, and this partnership is the clearest signal yet that we are delivering on that promise.”
— Mark Johnson, EVP Sales and Business Development, ProVoyance
Both companies will share more details about upcoming joint solutions in the near future.
About Interventional Systems
Interventional Systems (INS) is a medical device company developing innovative robotic solutions for minimally invasive surgery and percutaneous procedures. Its flagship product, Micromate™ is a versatile miniature robotic platform, cleared for 2D and 3D image-guided, needle-based procedures. INS is headquartered in Kitzbühel, Austria, with offices in Austria, Germany, and Portugal.
About ProVoyance
ProVoyance is a medical technology company providing AI-powered surgical planning platform technology to orthopedic OEM manufacturers. The company holds the first FDA clearance for an AI-enabled preoperative planning system in orthopedics (510(k) K210556), and licenses its regulatory-compliant platform to help OEM partners accelerate time to market and reduce development risk. ProVoyance is headquartered in Grand Rapids, Michigan.
